COMMUNIQUÉS West-GlobeNewswire

Humber River Health ranks among top Ontario hospitals in National Surgical Quality Improvement Program
17/09/2024
TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Humber River Health (Humber) is pleased to have ranked among the top five Ontario hospitals for every category of the American College of Surgeons’ (ACS) 2023 National [...]
Tiny Health Appoints Dr. Elisa Song as Chief Medical Officer and Dr. Taylor Sittler as Board Director
17/09/2024
Gut Health innovator strengthens practitioner-focused strategy with industry leaders in precision medicine AUSTIN, Texas, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Tiny Health , a pioneer in at-home microbiome testing for [...]
Stonebriar Facial and Oral Surgery to Open McKinney Location Sept. 27
17/09/2024
MCKINNEY, Texas and FRISCO, Texas, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stonebriar Facial and Oral Surgery , an oral and maxillofacial surgery (OMS) practice in Frisco, Texas, will open a new location in McKinney at 2164 [...]
Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
17/09/2024
-Capricor to Receive $15 Million Equity Investment at a 20% Premium, as well as $20 Million Upfront Payment upon Signing Definitive Agreement with up to $715 Million in Potential Milestones and a Double-Digit Percentage [...]
CSL Joins Accumulus Synergy to Drive Industry Change
17/09/2024
Following the launch of Accumulus Synergy’s innovative cloud-based information exchange platform, CSL joins the nonprofit industry association BURLINGAME, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, [...]
CSL rejoint Accumulus Synergy pour faire évoluer le secteur
17/09/2024
Suite au lancement de la plateforme innovante d’échange d’informations basée sur le cloud d’Accumulus Synergy, CSL rejoint l’association industrielle à but non lucratif BURLINGAME, Californie, 17 sept. 2024 (GLOBE [...]
QHSLab Announces Major Research and Development Milestones for 2024: Doubling Assessment Completion and Advancing Digital Medicine Innovation
17/09/2024
WEST PALM BEACH, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based [...]
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
17/09/2024
ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion expected by year end 2024 and commencement of dosing of ALS patients [...]
Foxo Technologies, Inc., Completes the Acquisition of Revenue Generating Operations From Rennova Health, Inc.
17/09/2024
Strategic Acquisitions Expected to Generate Over $20M in Annual Revenue, Positioning FOXO for Accelerated Growth MINNEAPOLIS, MN, Sept. 17, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “ [...]
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
17/09/2024
Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform AMSTERDAM, Sept. 17, 2024 (GLOBE NEWSWIRE) -- ( [...]
Merus Announces Abstract Accepted for Presentation at the ESMO Asia Congress 2024
17/09/2024
Petosemtamab in 2L+ HNSCC interim clinical data selected for rapid oral presentation UTRECHT, The Netherlands and CAMBRIDGE, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, [...]
Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology
17/09/2024
Enhanced longer version of Philips LumiGuide Navigation Wire enables US clinicians to visualize a broader range of catheters Internationally recognized vascular surgeon Carlos Timaran, MD, was the first to use the new [...]
KFSHRC at the forefront of precision medicine and genomic therapies in Saudi Arabia and the region
17/09/2024
RIYADH, Saudi Arabia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is integrating genomic profiling and pharmacogenomics into clinical practice. These enhancements [...]
Elicio Therapeutics Reports Inducement Grants
17/09/2024
BOSTON, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]
Employer Direct Healthcare Becomes Lantern; Adds New Infusion Offering, and Hires New Clinical Leadership
17/09/2024
Former Teladoc, CVS Health, and Hinge Health Executives Join Company’s Clinical Team as Specialty Care Platform Expands to Support People through Surgery, Cancer, and Infusion Therapy DALLAS, Sept. 17, 2024 (GLOBE [...]
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
17/09/2024
Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 BRAINTREE, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of [...]
INmune Bio Announces Results of Additional Blinded Interim Analysis of Phase 2 Alzheimer's Disease Trial Demonstrating Correlation between EMACC and CDR-SB Endpoints
17/09/2024
BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and inflammation company, today announced that results of additional analysis of blinded [...]
Alkeus Pharmaceuticals Announces Results from the SAGA Study of Oral Gildeuretinol in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
17/09/2024
Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy (GA) lesion growth rate at 24 months, supporting further clinical development. Gildeuretinol showed a statistically significant [...]
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
16/09/2024
Innovative drug treatment developed in collaboration with SciSparc aims to enhance safety and efficacy in mental health and addiction care Vancouver, Canada, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( [...]

Pages